Stratasys Releases Second Quarter 2021 Financial Results

Rhea-AI Summary

Stratasys Ltd. (NASDAQ: SSYS) reported strong second-quarter 2021 results with revenue reaching $147.0 million, a 25% increase from the previous year. GAAP gross margin improved to 43.0%, up from 37.2%. Operating losses decreased, with a GAAP loss of $22.7 million compared to $29.3 million last year. Non-GAAP net loss narrowed to $1.6 million, or $0.02 per diluted share. Adjusted EBITDA was $3.5 million, reflecting positive operational cash flow. The company anticipates 17% - 18% revenue growth in Q3 2021, emphasizing expansion in healthcare and manufacturing.

Positive

• Revenue increased by 25% year-over-year to $147.0 million.
• GAAP gross margin improved to 43.0%, up from 37.2%.
• Non-GAAP operating loss decreased to $2.6 million from $8.1 million.
• Adjusted EBITDA increased to $3.5 million from a loss of $1.6 million.
• Expecting 17% - 18% revenue growth in Q3 2021.

Negative

• GAAP operating loss of $22.7 million, though improved from previous year.

Stratasys Ltd. (NASDAQ: SSYS) announced financial results for the second quarter of 2021.

Second Quarter 2021 Financial Results Summary Compared to Second Quarter 2020:

• Revenue of $147.0 million compared to $117.6 million.
• GAAP gross margin was 43.0%, compared to 37.2%.
• Non-GAAP gross margin was 47.5%, compared to 45.4%.
• GAAP operating loss was $22.7 million, compared to an operating loss of $29.3 million.
• Non-GAAP operating loss was $2.6 million, compared to an operating loss of $8.1 million.
• GAAP net loss was $20.2 million, or $0.31 per diluted share, compared to a net loss of $28.0 million, or $0.51 per diluted share.
• Non-GAAP net loss was $1.6 million, or $0.02 per diluted share, compared to a net loss of $7.4 million, or $0.13 per diluted share.
• Adjusted EBITDA was $3.5 million, compared to $(1.6) million.
• Cash provided by operations of $5.6 million, compared to cash use of $9.7 million.

Dr. Yoav Zeif, Stratasys’s Chief Executive Officer stated, “Our strong second quarter results were highlighted by a 25% year over year revenue improvement with growth from all regions and all business lines. Our focus on manufacturing gained further traction, we increased the monetization and ecosystem partnerships of our software business, and we expanded our medical and dental offerings, advancing our plans for further penetration in the healthcare industry.”

Dr. Zeif continued, “The transition of the 3D printing industry from prototyping to mass production is ongoing, and our commitment to being the first choice in polymer 3D printing positions us to be the main benefactor. We are investing across technology, software, materials, and talent to capture increased market share that we expect will yield significant returns and sustained profitability in the years to come.”

Financial Outlook: (TBD)

Based on current market conditions and assuming that the impact related to the pandemic does not impede the economic environment further, the Company is reiterating and updating its outlook as follows:

• Third quarter 2021 revenue of approximately 17% - 18% growth year-over-year. Fourth quarter revenue is expected to be sequentially higher than third quarter.
• Full year operating expenses expected to rise approximately $30 million compared to 2020, primarily due to the return of employees to a full-time schedule starting January 1, 2021, as well as operating costs as the markets gradually re-open.
• Full year capital expenditures anticipated to range from $24 million to $30 million.
• Longer term, the Company continues to expect significant leverage benefit from its investments as revenue growth should start to accelerate in 2022 and beyond.

Stratasys Ltd. Second Quarter 2021 Webcast and Conference Call Details

The Company plans to webcast its conference call to discuss its second quarter 2021 financial results on Thursday, August 5, 2021 at 8:30 a.m. (ET).

The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com, or directly at the following web address:

https://78449.themediaframe.com/dataconf/productusers/ssys/mediaframe/46027/indexl.html

To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at investors.stratasys.com, or by accessing the above-provided web address.

Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products and healthcare. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.

To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the company’s websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.

Cautionary Statement Regarding Forward-Looking Statements

The statements in this press release regarding Stratasys' strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2021, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating acquisitions or investments in new businesses, technologies, products or services; the strength and duration of, and degree of recovery from, the COVID-19 pandemic in the markets in which we operate; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular (including risks related to the impact of coronavirus on our supply chain and business); costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2020, which we filed with the U.S. Securities and Exchange Commission, or SEC, on March 1, 2021 (the “2020 Annual Report”). Readers are urged to carefully review and consider the various disclosures made throughout our 2020 Annual Report and the Reports of Foreign Private Issuer on Form 6-K that attach Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2021, which will be furnished to the SEC throughout 2021 (including on or about the date hereof), and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Use of Non-GAAP Financial Measures

The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our Company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.

Stratasys Ltd.
Consolidated Balance Sheets
(Unaudited)
(in thousands, except share data)
		June 30,				December 31,
		2021				2020
ASSETS
Current assets
Cash and cash equivalents		$	343,733			$	272,092
Short-term deposits			179,000				27,000
Accounts receivable, net of allowance for credit losses of $0.8 and $0.9 million as of June 30, 2021 and December 31, 2020			109,969				106,068
Inventories			124,227				131,672
Prepaid expenses			7,288				6,717
Other current assets			21,189				16,943
Total current assets			785,406				560,492
Non-current assets
Property, plant and equipment, net			201,080				201,232
Goodwill			39,686				35,694
Other intangible assets, net			124,257				131,569
Operating lease right-of-use assets			17,514				21,298
Other non-current assets			55,081				39,717
Total non-current assets			437,618				429,510
Total assets		$	1,223,024			$	990,002
LIABILITIES AND EQUITY
Current liabilities
Accounts payable		$	42,001			$	16,987
Accrued expenses and other current liabilities			30,134				31,061
Accrued compensation and related benefits			29,270				25,659
Deferred revenues - short term			48,943				49,165
Operating lease liabilities - short term			8,248				9,282
Total current liabilities			158,596				132,154
Non-current liabilities
Deferred revenues - long term			15,661				14,227
Operating lease liabilities - long term			9,553				12,567
Contingent consideration			40,436				37,400
Other non-current liabilities			37,206				34,059
Total non-current liabilities			102,856				98,253
Total liabilities			261,452				230,407
Redeemable non-controlling interests			227				227
Equity
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 65,396 thousands shares and 56,617 thousands shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively			181				155
Additional paid-in capital			2,992,833				2,753,955
Accumulated other comprehensive loss			(6,703	)			(8,846	)
Accumulated deficit			(2,024,966	)			(1,985,896	)
Total equity			961,345				759,368
Total liabilities and equity		$	1,223,024			$	990,002

Stratasys Ltd.
Consolidated Statements of Operations
(in thousands, except per share data)
		Three Months Ended June 30,								Six Months Ended June 30,
		2021				2020				2021				2020
		(unaudited)				(unaudited)				(unaudited)				(unaudited)
Net sales
Products		$	100,305			$	73,877			$	190,629			$	157,049
Services			46,700				43,746				90,565				93,481
			147,005				117,623				281,194				250,530
Cost of sales
Products			49,731				39,969				96,651				79,217
Services			34,004				33,918				65,696				67,707
			83,735				73,887				162,347				146,924
Gross profit			63,270				43,736				118,847				103,606
Operating expenses
Research and development, net			22,437				21,303				43,038				45,497
Selling, general and administrative			63,557				51,711				116,891				107,287
			85,994				73,014				159,929				152,784
Operating loss			(22,724	)			(29,278	)			(41,082	)			(49,178	)
Financial income (expenses), net			(372	)			149				(749	)			(680	)
Loss before income taxes			(23,096	)			(29,129	)			(41,831	)			(49,858	)
Income tax benefit			(4,368	)			(2,128	)			(5,310	)			(1,907	)
Share in losses of associated companies			(1,431	)			(950	)			(2,549	)			(1,788	)
Net loss			(20,159	)			(27,951	)			(39,070	)			(49,739	)
Net income (loss) attributable to non-controlling interests			-				35				-				(50	)
Net loss attributable to Stratasys Ltd.		$	(20,159	)		$	(27,986	)		$	(39,070	)		$	(49,689	)
Net loss per ordinary share attributable to Stratasys Ltd.
Basic		$	(0.31	)		$	0.51			$	(0.63	)		$	(0.91	)
Diluted		$	(0.31	)		$	0.51			$	(0.63	)		$	(0.91	)
Weighted average ordinary shares outstanding
Basic			64,908				54,917				61,796				54,733
Diluted			64,908				54,917				61,796				54,733

			Three Months Ended June 30,
			2021				Non-GAAP				2021				2020				Non-GAAP				2020
			GAAP				Adjustments				Non-GAAP				GAAP				Adjustments				Non-GAAP
			U.S. dollars and shares in thousands (except per share amounts)
	Gross profit (1)		$	63,270			$	6,616			$	69,886			$	43,736			$	9,612			$	53,348
	Operating income (loss) (1,2)			(22,724	)			20,133				(2,591	)			(29,278	)			21,228				(8,050	)
	Net income (loss) attributable to Stratasys Ltd. (1,2,3)			(20,159	)			18,581				(1,578	)			(27,986	)			20,634				(7,352	)
	Net income (loss) per diluted share attributable to Stratasys Ltd. (4)		$	(0.31	)		$	0.29			$	(0.02	)		$	(0.51	)		$	0.38			$	(0.13	)
(1)	Acquired intangible assets amortization expense							5,518												4,065
	Non-cash stock-based compensation expense							788												497
	Restructuring and other related costs							310												5,050
								6,616												9,612
(2)	Acquired intangible assets amortization expense							2,200												2,125
	Non-cash stock-based compensation expense							7,189												5,614
	Restructuring and other related costs							350												3,798
	Revaluation of investments							2,201												-
	Contingent consideration							202												-
	Other expenses							1,375												79
								13,517												11,616
								20,133												21,228
(3)	Corresponding tax effect							(1,637	)											(669	)
	Equity method related amortization, divestments and impairments							85												75
							$	18,581											$	20,634
(4)	Weighted average number of ordinary shares outstanding- Diluted			64,908								64,908				54,917								54,917

			Six Months Ended June 30,
			2021				Non-GAAP				2021				2020				Non-GAAP				2020
			GAAP				Adjustments				Non-GAAP				GAAP				Adjustments				Non-GAAP
			U.S. dollars and shares in thousands (except per share amounts)
	Gross profit (1)		$	118,847			$	13,685			$	132,532			$	103,606			$	14,026			$	117,632
	Operating income (loss) (1,2)			(41,082	)			35,918				(5,164	)			(49,178	)			32,719				(16,459	)
	Net income (loss) attributable to Stratasys Ltd. (1,2,3)			(39,070	)			33,692				(5,378	)			(49,689	)			31,771				(17,919	)
	Net income (loss) per diluted share attributable to Stratasys Ltd. (4)		$	(0.63	)		$	0.55			$	(0.09	)		$	(0.91	)		$	0.58			$	(0.33	)
(1)	Acquired intangible assets amortization expense							10,873												8,130
	Non-cash stock-based compensation expense							1,422												899
	Restructuring and other related costs							1,390												4,997
								13,685												14,026
(2)	Acquired intangible assets amortization expense							4,393												4,267
	Non-cash stock-based compensation expense							13,760												10,119
	Restructuring and other related costs							2,159												3,829
	Revaluation of investments							(1,469	)											-
	Contingent consideration							393												-
	Other expenses							2,997												478
								22,233												18,693
								35,918												32,719
(3)	Corresponding tax effect							(2,394	)											(1,100	)
	Equity method related amortization, divestments and impairments							168												152
							$	33,692											$	31,771
(4)	Weighted average number of ordinary shares outstanding- Diluted			61,796								61,796				54,733								54,733

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20210805005233/en/

FAQ

What were Stratasys's Q2 2021 revenue results?

Stratasys reported second-quarter 2021 revenue of $147.0 million, a 25% increase compared to the same quarter in 2020.

How did Stratasys's gross margin change in Q2 2021?

The GAAP gross margin for Stratasys in Q2 2021 improved to 43.0%, compared to 37.2% in Q2 2020.

What is the outlook for Stratasys in Q3 2021?

Stratasys expects revenue growth of approximately 17% - 18% year-over-year in Q3 2021.

What was the non-GAAP net loss for Stratasys in Q2 2021?

The non-GAAP net loss for Stratasys in Q2 2021 was $1.6 million, or $0.02 per diluted share.

What significant changes did Stratasys report in operating expenses?

Stratasys expects full year operating expenses to increase by approximately $30 million compared to 2020.